NCT03591003View on ClinicalTrials.gov

"Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2023

Study Completion Date

March 31, 2023

Conditions
HIV InfectionsYellow Fever Vaccine
Interventions
DIAGNOSTIC_TEST

Yellow fever neutralizing antibodies measure

Yellow fever neutralizing antibodies measure before vaccination, within the year after vaccination and at any delay after vaccination

Trial Locations (12)

1000

Centre Hospitalier Universitaire Saint-Pierre, Brussels

1070

Hôpital Erasme, Brussels

1090

UZ Brussel, Jette

1200

Cliniques Universitaires Saint-Luc, Brussels

2000

Instituut voor Tropische Geneeskunde, Antwerp

3000

UZ Leuven, Leuven

3500

Jessa Ziekenhuis, Hasselt

4000

Centre Hospitalier Universitaire de Liège, Liège

5500

CHU Dinat Godinne, Dinant

6000

CHU Charleroi Marie Curie, Charleroi

8000

AZ Sint-Jan Brugge, Bruges

9000

UZ Gent, Ghent

All Listed Sponsors
lead

Centre Hospitalier Universitaire Saint Pierre

OTHER

NCT03591003 - "Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients" | Biotech Hunter | Biotech Hunter